Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 6/20 | 1.00 |
| ▸ | NR3C2 | P08235 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SHBG | P04278 | 4/20 | 1.00 |
| ▸ | SERPINA6 | P08185 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | SLC22A2 | O15244 | 1/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 1.00 |
| ▸ | SLC22A3 | O75751 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epicorticosterone SCHEMBL19465689 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Corticosterone SCHEMBL22612 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Epicorticosterone SCHEMBL14592717 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Epicorticosterone SCHEMBL17287012 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Corticosterone SCHEMBL5669349 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Epicorticosterone SCHEMBL20058459 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Epicorticosterone SCHEMBL9070639 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Epicorticosterone SCHEMBL15920519 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Epicorticosterone SCHEMBL21168995 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG | |
| Epicorticosterone SCHEMBL20242898 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2HIF1ANR3C2LMNASHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220370620-A1 | DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-11-24 | — | — | US | disclosed |
| WO-2021005417-A1 | SURFACE COATINGS AND IMPLANTABLE DEVICES COMPRISING DIMERIC STEROID PRODRUGS, AND USES THEREOF | RIPPLE THERAPEUTICS CORPORATIONS (CA) | 2021-01-14 | — | — | WO | disclosed |
| US-20200368358-A1 | DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2020-11-26 | — | — | US | disclosed |
| US-10736965-B2 | Risperidone biodegradable implant | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2020-08-11 | — | — | US | disclosed |
| EP-2776040-B1 | 4-PREGENEN-11SS-17-21-TRIOL-3,20-DIONE DERIVATIVES FOR THE TREATMENT OF OCULAR CONDITIONS | ALLERGAN INC (US) | 2020-04-22 | — | — | EP | disclosed |
| US-20190105396-A1 | DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2019-04-11 | — | — | US | disclosed |
| WO-2019054822-A1 | ACTIVE SUBSTANCE-HEXAPEPTIDE COMPLEX AND COSMETIC COMPOSITION CONTAINING SAME | 애니젠 주식회사 | 2019-03-21 | — | — | WO | disclosed |
| WO-2019055028-A1 | PARTICLES, COMPOSITIONS, AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | KALA PHARMACEUTICALS, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| EP-3309166-A2 | 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION | Sphaera Pharma Pvt. Ltd. (IN) | 2018-04-18 | — | — | EP | disclosed |
| US-9925268-B2 | Drug-containing implants and methods of use thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2018-03-27 | — | — | US | disclosed |
| US-20170319701-A1 | DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2017-11-09 | — | — | US | disclosed |
| US-9717799-B2 | Drug-containing implants and methods of use thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160361421-A1 | DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2016-12-15 | — | — | US | disclosed |
| US-8802127-B2 | Risperidone-containing PLA:PGA implants and methods of use thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2014-08-12 | — | — | US | disclosed |
| US-8741327-B2 | Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2014-06-03 | — | — | US | disclosed |
| US-20130064773-A1 | DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2013-03-14 | — | — | US | disclosed |
| US-8329203-B2 | Drug-containing implants and methods of use thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2012-12-11 | — | — | US | disclosed |
| US-7645885-B2 | Non-steroidal antiandrogens | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-01-12 | — | — | US | disclosed |
| US-20090297572-A1 | Drug-Containing Implants And Methods of Use Thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2009-12-03 | — | — | US | disclosed |
| US-20060159721-A1 | Drug-containing implants and methods of use thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2006-07-20 | — | — | US | disclosed |